News & Events

Keep up to date with the latest news and check out where our team will be headed this event season.

Vibalogics Completes 118,000 ft² GMP Facility in Massachu…

New Massachusetts facility enables focused end-to-end virotherapy CDMO services Today, Vibalogics celebrates completion of the first ph…

The Medicine Maker: A New Focus for Cancer Therapeutics

The Medicine Maker recently featured Joe Sinclair, Vice President, Business Development & Corporate Strategy at Vibalogics exploring the t…

Lab Manager: Virotherapy GMP Site Expands to Enhance Flexibility

Stefan Beyer, PhD, President and Managing Director recently sat down with Lab Manager to discuss ongoing expansion of Vibalogics' Cuxhaven, Ge…

Vibalogics Establishes Scientific Advisory Board with Lea…

Vibalogics, a global contract development and manufacturing organization (CDMO) and recognized leader in the virotherapy services market, has …

BioProcess International: CDMOs are now the leaders in th…

Roger Lias, PhD, Chief Commercial Officer recently sat down with BioProcess International to discuss how "CDMOs are now the leaders in the bio…

Vibalogics Advances Growth with Key Global Commercial Lea…

Vibalogics, a global contract development and manufacturing organization (CDMO) specializing in the production of oncolytic viruses, viral vec…